MoneyWorks4Me

Neuland Laboratories - Quaterly Results

15 May 2025 Evaluate
The sales declined to Rs. 3283.60 millions for the March 2025 quarter as compared to Rs. 3850.10 millions during the corresponding quarter last year.The Net Profit of the company slipped to Rs. 277.34 millions from Rs. 676.06 millions, a decline of -58.98% on QoQ basis.The company reported a degrowth in operating Profit to 582.18 millions from 1121.51 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 3283.60 3850.10 -14.71 14768.37 15585.80 -5.24 14768.37 15585.80 -5.24
Other Income 74.64 53.57 39.33 205.09 125.44 63.50 205.09 125.44 63.50
PBIDT 582.18 1121.51 -48.09 3428.08 4744.65 -27.75 3428.08 4744.65 -27.75
Interest 23.46 36.09 -35.00 82.96 139.97 -40.73 82.96 139.97 -40.73
PBDT 558.72 1085.42 -48.52 4109.16 4604.68 -10.76 4109.16 4604.68 -10.76
Depreciation 168.90 164.62 2.60 655.42 596.99 9.79 655.42 596.99 9.79
PBT 389.82 920.80 -57.67 3453.74 4007.69 -13.82 3453.74 4007.69 -13.82
TAX 112.48 244.74 -54.04 859.48 1011.73 -15.05 859.48 1011.73 -15.05
Deferred Tax 53.11 25.50 108.27 122.95 15.87 674.73 122.95 15.87 674.73
PAT 277.34 676.06 -58.98 2594.26 2995.96 -13.41 2594.26 2995.96 -13.41
Equity 129.01 129.01 0.00 129.01 129.01 0.00 129.01 129.01 0.00
PBIDTM(%) 17.73 29.13 -39.13 23.21 30.44 -23.75 23.21 30.44 -23.75
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..